Literature DB >> 25089339

A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab.

Omid Bakhtar1, Bijin Thajudeen, Beth L Braunhut, Sarah E Yost, Erika R Bracamonte, Amy N Sussman, Bruce Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25089339     DOI： 10.1097/TP.0000000000000267

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  9 in total

Review 1.  Systemic lupus erythematosus biomarkers: the challenging quest.

Authors:  Cristina Arriens; Jonathan D Wren; Melissa E Munroe; Chandra Mohan
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

Review 2.  Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.

Authors:  Maria Izabel de Holanda; Luis Cristóvão Pôrto; Teresa Wagner; Luis Fernando Christiani; Lilian M P Palma
Journal:  Clin Rheumatol       Date:  2017-09-13       Impact factor: 2.980

Review 3.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

4.  Methimazole-Induced Pauci-Immune Glomerulonephritis and Anti-Phospholipid Syndrome: An Important Association to Be Aware of.

Authors:  Huzaif Qaisar; Mohammad A Hossain; Monika Akula; Jennifer Cheng; Mayurkumar Patel; Zheng Min; Halyna Kuzyshyn; Michael Levitt; Shana M Coley; Arif Asif
Journal:  J Clin Med Res       Date:  2018-09-10

5.  Atypical hemolytic uremic syndrome: a syndrome in need of clarity.

Authors:  Bruce E Berger
Journal:  Clin Kidney J       Date:  2018-07-31

Review 6.  Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?

Authors:  Ilaria Mormile; Francescopaolo Granata; Alessandra Punziano; Amato de Paulis; Francesca Wanda Rossi
Journal:  Biomedicines       Date:  2021-02-01

Review 7.  The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome.

Authors:  Doruk Erkan; Jane E Salmon
Journal:  Turk J Haematol       Date:  2016-03-05       Impact factor: 1.831

8.  Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.

Authors:  Vicky Brocklebank; David Kavanagh
Journal:  Clin Kidney J       Date:  2017-05-08

9.  16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.

Authors:  Hannah Cohen; Maria J Cuadrado; Doruk Erkan; Ali Duarte-Garcia; David A Isenberg; Jason S Knight; Thomas L Ortel; Anisur Rahman; Jane E Salmon; Maria G Tektonidou; David J Williams; Rohan Willis; Scott C Woller; Danieli Andrade
Journal:  Lupus       Date:  2020-10       Impact factor: 2.911
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.